Table 1. Status of TET1 expression level in gastric tumors with respect to clinicopathological characteristics.
Characteristics | TET1 high (27/80) | TET1 low (53/80) | P value | |
---|---|---|---|---|
Age (years) | 58.07 ± 13.12 | 56.96 ± 13.87 | 0.7309a | |
Tumor size (cm) | 5.39 ± 2.27 | 5.39 ± 2.05 | 0.9940a | |
Gender | ||||
Male | 13 | 33 | 0.227b | |
Female | 14 | 20 | ||
Histology | ||||
Intestinal | 12 | 23 | 0.928b | |
Diffuse | 15 | 30 | ||
Stage | ||||
EGC | 5 | 2 | 0.027c | |
AGC | 22 | 51 | ||
Lymph node metastasis | ||||
Negative | 16 | 17 | 0.019b | |
Positive | 11 | 36 |
All tumors were classified into two subtypes using average TET1 expression.
Tumor size was calculated based on the largest diameter measured for each tumor.
EGC, early gastric cancer; AGC, advanced gastric cancer.
P value was measured with the Student's t test.
Significance of association was determined using the χ2 test.
Analyzed with Fisher's exact test.